![Martin Tolstrup](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Martin Tolstrup
Corporate Officer/Principal at Århus Universitetshospital
Profile
Martin Tolstrup is the founder of EnFutech ApS and iSD Immunotech ApS, both founded in 2007.
He is currently working as a Laboratory Head at Århus Universitetshospital.
Martin Tolstrup active positions
Companies | Position | Start |
---|---|---|
Århus Universitetshospital
![]() Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Corporate Officer/Principal | - |
Former positions of Martin Tolstrup
Companies | Position | End |
---|---|---|
iSD Immunotech ApS
![]() iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Founder | - |
EnFutech ApS
![]() EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
EnFutech ApS
![]() EnFutech ApS BiotechnologyHealth Technology EnFutech ApS is a holding company that develops technologies for prevention, treatment, and eradication of Human Immunodeficiency Virus (HIV). Its platforms include both a new type of inhibitor that can be used as a prophylactic agent as well as a traditional drug for treatment of infection and a gene therapeutical approach to rendering the T-cells immune to HIV infection. The firm aims to combat infection, by developing effective anti-HIV treatments that can remove the virus both before and after it infects human cells. Its treatment is based on its novel technologies of blocking the HIV co-receptors using retargeted envelope proteins and receptor interference. The company was founded by Finn Skou Pedersen and Martin Tolstrup on August 23, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
iSD Immunotech ApS
![]() iSD Immunotech ApS BiotechnologyHealth Technology iSD Immunotech ApS develops immunoregulatory peptides and proteins. It conducts research and development on immunoregulatory peptides for possible applications and commercialization. The company was founded by Peter Samuel Wulff, Shervin Bahrami, Finn Skou Pedersen, Mogens Ryttergård Duch, Lars Jørgen Østergaard, Martin Tolstrup, and Martin Thygesen on August 9, 2007 and is headquartered in Aarhus, Denmark. | Health Technology |
Århus Universitetshospital
![]() Århus Universitetshospital Hospital/Nursing ManagementHealth Services Aarhus Universitetshospital is a highly specialized hospital located in Aarhus, DK. Aarhus Universitetshospital has been named Denmark's best hospital several times and is known for its specialized medical services. The hospital has subsidiaries in Denmark. The Danish company was founded in 2011, and Poul Blaabjerg has been the CEO of the company since 2017. | Health Services |
- Stock Market
- Insiders
- Martin Tolstrup